Mind Medicine (MindMed) Inc.

05/29/2024 | Press release | Distributed by Public on 05/29/2024 06:19

MindMed ASCP 2024: Improvement in Functional and Sexual Disability and Quality of Life After One Dose of MM120 (Lysergide) in Generalized Anxiety Disorder